Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Cash & Equivalents (2016 - 2025)

Myomo's Cash & Equivalents history spans 10 years, with the latest figure at $12.6 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 79.4% year-over-year to $12.6 million; the TTM value through Sep 2025 reached $12.6 million, up 79.4%, while the annual FY2024 figure was $24.4 million, 254.7% up from the prior year.
  • Cash & Equivalents reached $12.6 million in Q3 2025 per MYO's latest filing, down from $14.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $24.4 million in Q4 2024 to a low of $5.3 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $11.3 million, with a median of $10.2 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: tumbled 65.56% in 2022, then skyrocketed 271.11% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $15.5 million in 2021, then crashed by 65.56% to $5.3 million in 2022, then increased by 28.53% to $6.9 million in 2023, then surged by 254.7% to $24.4 million in 2024, then plummeted by 48.49% to $12.6 million in 2025.
  • Per Business Quant, the three most recent readings for MYO's Cash & Equivalents are $12.6 million (Q3 2025), $14.6 million (Q2 2025), and $20.2 million (Q1 2025).